These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15673320)

  • 1. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions.
    Nikolsky E; Mehran R; Lasic Z; Mintz GS; Lansky AJ; Na Y; Pocock S; Negoita M; Moussa I; Stone GW; Moses JW; Leon MB; Dangas G
    Kidney Int; 2005 Feb; 67(2):706-13. PubMed ID: 15673320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
    Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
    Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
    Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
    Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
    Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
    Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
    Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
    Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower blood vitamin D levels are associated with an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography.
    Sahin I; Gungor B; Can MM; Avci II; Guler GB; Okuyan E; Biter H; Yildiz SS; Ayca B; Satilmis S; Dinckal MH
    Can J Cardiol; 2014 Apr; 30(4):428-33. PubMed ID: 24680172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
    Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
    Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions.
    Chong E; Poh KK; Liang S; Soon CY; Tan HC
    J Interv Cardiol; 2010 Oct; 23(5):451-9. PubMed ID: 20796168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
    Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
    Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprocedural drop in hematocrit versus contrast-induced nephropathy: eggs or chickens?
    Lai MY; Lin CC; Yang WC
    Kidney Int; 2005 Sep; 68(3):1371-2; author reply 1372. PubMed ID: 16105079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.